You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 40 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Disulfiram for Alcoholics in Methadone Maintenance Programs

A Veterans Administration Cooperative Study

Walter Ling, MD; David G. Weiss, PhD; V. Charles Charuvastra, MD; Charles P. O'Brien, MD, PhD; Mara Blakis, MD; Richard Wang, MD; Charles Savage, MD; Douglas Roszell, MD; Edward L. Way, PhD; Joyce McIntyre, MS

Arch Gen Psychiatry. 1983;40(8):851-854.


Abstract

• A multicentered clinical trial studied the efficacy and safety of disulfiram in controlling heavy alcohol consumption by patients on methadone maintenance regimens. The trial was stopped when sample size targets were not achieved. Efficacy comparisons were based on 82 patients who started the study; safety comparisons were based on 35 patients who completed 12 weeks of study. Patients received either disulfiram and methadone or placebo and methadone. Disulfiram was administered at a dosage of 125 mg/day for seven days and 250 mg/day thereafter for 36 weeks. No significant differences between the disulfiram and placebo groups were observed in either the retention in study or any other important end point. Both groups showed improvement in control of drinking during the study. There were no serious adverse reactions that could be attributed to the combined use of the two drugs.



Author Affiliations

From the Veterans Administration Medical Centers at Sepulveda, Calif (Drs Ling and Blakis and Ms McIntyre), Perry Point, Md (Dr Weiss), Philadelphia (Dr O'Brien), Los Angeles (Dr Charuvastra), Wood, Wis (Dr Wang), Baltimore (Dr Savage), and Seattle (Dr Roszell); and the University of California at San Francisco (Dr Way).


Footnotes

Accepted for publication Jan 5, 1983.

Reprint requests to Drug Dependency Treatment Center, Veterans Administration Medical Center, 16111 Plummer St, Sepulveda, CA 91343 (Dr Ling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.